PMV Pharma director Matthew Joseph Eckler files initial beneficial ownership statementPUBT·Oct 5, 2026 at 08:04 PMPMVP-6.20%
Biotech Stocks At 52-Week Highs - KOD, MASS, OBIO, CDNA, PMVPrttnews·Oct 2, 2026 at 07:28 AMCDNA-4.01%KOD-2.69%
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Receives Consensus Rating of "Moderate Buy" from BrokeragesMarket Beat·Sep 4, 2026 at 12:14 PMPMVP-6.20%
PMV Pharmaceuticals Enters Underwriting Agreement With TD Securities for ~$47 Million OfferingTradingView·Sep 2, 2026 at 10:03 AMPMVP-6.20%
Craig-Hallum Sticks to Their Buy Rating for PMV Pharmaceuticals (PMVP)Tip Ranks·Sep 1, 2026 at 03:15 PMPMVP-6.20%
PMV Pharma Raises $50.8 Million to Fuel Cancer Drug Pushbenzinga_article·Sep 1, 2026 at 01:01 PMPMVP-6.20%
Why Pyxis Tankers Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarketbenzinga_article·Sep 1, 2026 at 08:35 AMPMVP-6.20%SSM0.00%
PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities | PMVP Stock NewsStockTitan·Aug 31, 2026 at 07:03 PMPMVP-6.20%TD+0.52%
